Mismatch repair proficiency and in vitro response to 5-fluorouracil

Slides:



Advertisements
Similar presentations
Over Expression of CD44V8—10 in Human Bladder Cancer Cells Decreases Their Interaction With Hyaluronic Acid and Potentiates Their Malignant Progression 
Advertisements

Volume 114, Issue 5, Pages (May 1998)
The effects of folic acid on global DNA methylation and colonosphere formation in colon cancer cell lines  Nathan Farias, Nelson Ho, Stacey Butler, Leanne.
Volume 133, Issue 1, Pages (July 2007)
Comparison of a tetravalent single-chain antibody-streptavidin fusion protein and an antibody-streptavidin chemical conjugate for pretargeted anti-CD20.
Synthetic smooth muscle cell phenotype is associated with increased nicotinamide adenine dinucleotide phosphate oxidase activity: Effect on collagen secretion 
CDK2 is highly expressed in colon cancer cells and curcumin selectively suppresses HCT116 cell proliferation. CDK2 is highly expressed in colon cancer.
Yunguang Sun, PhD, Luigi Moretti, MD, Nicholas J
Volume 122, Issue 3, Pages (March 2002)
Volume 133, Issue 1, Pages (July 2007)
Volume 117, Issue 4, Pages (October 1999)
Volume 129, Issue 3, Pages (September 2005)
Volume 115, Issue 5, Pages (November 1998)
Volume 114, Issue 5, Pages (May 1998)
Volume 118, Issue 1, Pages (January 2000)
PTF1α/p48 and cell proliferation
Volume 123, Issue 2, Pages (August 2002)
Hyaluronate-Enhanced Hematopoiesis: Two Different Receptors Trigger the Release of Interleukin-1β and Interleukin-6 From Bone Marrow Macrophages by Sophia.
Volume 132, Issue 3, Pages (March 2007)
Volume 134, Issue 1, Pages (January 2008)
Volume 120, Issue 1, Pages (January 2001)
Adam Belley, Kris Chadee  Gastroenterology 
Volume 117, Issue 4, Pages (October 1999)
Volume 119, Issue 4, Pages (October 2000)
Volume 115, Issue 2, Pages (August 1998)
Volume 128, Issue 1, Pages 9-23 (January 2005)
Suppression of fibroblast growth factor receptor signaling inhibits pancreatic cancer growth in vitro and in vivo  Markus Wagner, Martha E. Lopez, Mitch.
Dominique Velin, Daniel Bachmann, Hanifa Bouzourene, Pierre Michetti 
DNAPKcs is required for DNA repair in the presence of androgen.
Volume 115, Issue 2, Pages (August 1998)
Volume 14, Issue 1, Pages (July 2013)
Molecular Therapy - Nucleic Acids
Volume 117, Issue 3, Pages (September 1999)
Volume 120, Issue 4, Pages (March 2001)
Molecular Therapy - Oncolytics
Volume 135, Issue 2, Pages (August 2008)
Cell-Density-Dependent Regulation of Expression and Glycosylation of Dopachrome Tautomerase/Tyrosinase-Related Protein-2  Thomas J. Hornyak, Daniel J.
Volume 116, Issue 6, Pages (June 1999)
Volume 115, Issue 1, Pages (July 1998)
Volume 123, Issue 1, Pages (July 2002)
FGF-7 Expression Enhances the Performance of Bioengineered Skin
This Month in Gastroenterology
Molecular Therapy - Oncolytics
Volume 116, Issue 6, Pages (June 1999)
Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells  Jeffrey A. Brockman, Rajnish A. Gupta, Raymond.
A Major Role for Capsule-Independent Phagocytosis-Inhibitory Mechanisms in Mammalian Infection by Cryptococcus neoformans  Cheryl D. Chun, Jessica C.S.
Volume 12, Issue 5, Pages (November 2005)
Elizabeth M Hadac, Elizabeth J Kelly, Stephen J Russell 
P300 depletion is lethal in cancer cells harboring loss-of-function mutations in CBP. A, synthetic-lethal effects assessed by colony formation assay. p300.
Ajay Gautam, Charles L. Densmore, J.Clifford Waldrep  Molecular Therapy 
Volume 116, Issue 2, Pages (February 1999)
Angiotensin II stimulates Pax-2 in rat kidney proximal tubular cells: Impact on proliferation and apoptosis  Shao-Ling Zhang, Jun Guo, Babak Moini, Julie.
Volume 127, Issue 6, Pages (December 2004)
Mechanism of inhibition of matrix metalloproteinase-2 expression by doxycycline in human aortic smooth muscle cells  Jian Liu, MD, Wanfen Xiong, PhD,
Volume 114, Issue 5, Pages (May 1998)
Volume 10, Issue 6, Pages (December 2004)
Fig. 1. CAR4 and CAR8 cells demonstrate in vitro and in vivo antileukemic efficacy. CAR4 and CAR8 cells demonstrate in vitro and in vivo antileukemic efficacy.
Molecular Therapy - Nucleic Acids
PX-478 directly radiosensitizes tumor cells in vitro.
A. A. XPCKD and KIN17KD HeLa cells grow poorly 2 weeks after transfection. Forty-eight hours after transfection, cells were plated at the same density.
Anti-Flk-1 treatment inhibits growth of s. c. 4T1 and B16 tumors. s. c
Volume 9, Issue 4, Pages (April 2004)
Endogenously produced n-3 PUFAs inhibit endometrial cancer cell growth in vitro and in vivo. Endogenously produced n-3 PUFAs inhibit endometrial cancer.
Neurotensin and insulin induce increases in CTGF, CYR61, and CXCL5 gene expression and stimulate cell proliferation and colony via YAP/TAZ in PDAC cells.
Effect of SPINDLIN1 protein on cancer cell proliferation and invasion.
Volume 114, Issue 1, Pages (January 1998)
Efficacy of KM100 and/or MTX in BALB/c mice bearing subcutaneous TUBO tumors. Efficacy of KM100 and/or MTX in BALB/c mice bearing subcutaneous TUBO tumors.
Volume 118, Issue 3, Pages (March 2000)
Validation of KMT2D function in MM23, MM2, and MM25 PDXs
DHA and dietary n-3 PUFAs inhibit endometrial cancer cell growth in vitro and in xenograft models. DHA and dietary n-3 PUFAs inhibit endometrial cancer.
Presentation transcript:

Mismatch repair proficiency and in vitro response to 5-fluorouracil John M. Carethers*,‡, Dharam P. Chauhan*, Daniel Fink*, Sibylle Nebel*, Robert S. Bresalier§, Stephen B. Howell*,‡, C.Richard Boland*,‡,∥  Gastroenterology  Volume 117, Issue 1, Pages 123-131 (July 1999) DOI: 10.1016/S0016-5085(99)70558-5 Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 1 Tumorigenicity of HCT116 (•), HCT116+ch2 (■), and HCT116+ch3 (▴) cell lines. Each cell line was grown in Dulbecco's modified Eagle medium with 10% FBS in 7% CO2 and injected into the left flank of 5 BALB/c NCR-NU athymic mice, performed in duplicate. Tumor volume was calculated at each time point by the method in Kwan et al.36 Each point represents the mean ± SD. Gastroenterology 1999 117, 123-131DOI: (10.1016/S0016-5085(99)70558-5) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 2 Colony-forming ability of MMR-deficient and -proficient cell lines in response to 5-FU. Cells were plated in media containing 0, 1, 2.5, or 5 μmol/L 5-FU and allowed to form colonies over a 10-day period. The plates were then fixed with methanol and stained with 3% Giemsa, and previously viable colonies were counted. The mean number of colonies obtained after 10 days for untreated cells were (plating factor of 103): HCT116, 390; HCT116+ch2, 438; HCT116+ch3, 602.5; SW480, 610; LoVo, 176; and 2774, 385. Results are expressed as the mean ± SE of the relative surviving fraction. Data are from 5 independent experiments. MMR-proficient cell lines are noted with the asterisk. Gastroenterology 1999 117, 123-131DOI: (10.1016/S0016-5085(99)70558-5) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 3 Incorporation of 3H–5-FU into nucleic acids of HCT116, HCT116+ch2, and HCT116+ch3 cell lines. Cells were coincubated with 1 μmol/L 3H–5-FU and 10 μCi/mL of H3-32PO4 for 24 hours. The nucleic acids were separated by a cesium chloride gradient and fractionated. Linear regression was determined by cesium chloride density for each fraction. The 3H–5-FU and H3-32PO4 counts banding in the RNA region (between density 1.62 and 1.68 g/mL) and DNA region (between density 1.42 and 1.48 g/mL) of the gradient were determined and used as a measure of the incorporation of 5-FU and phosphate.28 The RNA to DNA ratio is the total tritium counts per minute from the RNA fraction divided by the total counts per minute from the DNA fraction. Results are from 2 independent experiments. Gastroenterology 1999 117, 123-131DOI: (10.1016/S0016-5085(99)70558-5) Copyright © 1999 American Gastroenterological Association Terms and Conditions